Insider · CIK 0001738896
Duncan McHale
Files at EVLO (Evelo Biosciences, Inc.). First filing Nov 3, 2023, latest Nov 8, 2023.
In brief
Duncan McHale files SEC Form 4 as officer at EVLO (Evelo Biosciences, Inc.). Since Nov 3, 2023, Duncan McHale has reported 0 open-market buys worth $0 and 2 open-market sells worth $3,286, the latest filed on Nov 8, 2023.
A track record needs three past buys with six months of prices behind them; Duncan McHale has 0, so none is measured yet.
The newest scored trade: sold $1,024 of EVLO on Nov 8, 2023, filed Nov 8, 2023, scored 0 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVLO: Evelo Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Evelo Biosciences, Inc. | $1,024 3,103 shares | -15% | - | |
| 5Weak | Evelo Biosciences, Inc. | $2,262 6,854 shares | -34% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +6,500 | - | - | 20,087 | Nov 8, 2023 |
| Nov 8, 2023 | EVLO Evelo Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -3,103 | $0.33 | $1,024 | 16,984 | Nov 8, 2023 |
| Nov 7, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -6,500 | $0.00 | $0 | 6,500 | Nov 8, 2023 |
| Nov 1, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +12,500 | - | - | 20,441 | Nov 3, 2023 |
| Nov 2, 2023 | EVLO Evelo Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -6,854 | $0.33 | $2,262 | 13,587 | Nov 3, 2023 |
| Nov 1, 2023 | EVLO Evelo Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -12,500 | $0.00 | $0 | 25,000 | Nov 3, 2023 |
Questions about Duncan McHale
Answered from the filings on this page, as of the latest one.
Is Duncan McHale buying or selling?
Not in the last 12 months. Duncan McHale's latest open-market trade on SEC Form 4 was sold $1,024 of EVLO on Nov 8, 2023.
How did Duncan McHale's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Duncan McHale has 0.
Where does Duncan McHale file Form 4?
Duncan McHale has filed Form 4 at EVLO (Evelo Biosciences, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.